Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 | $392.9M | -- | -- | -$0.18 | -- |
| 11/03/2025 | Q3 | $382.1M | $388.7M | -$0.68 | -$0.23 | -$0.45 |
| 08/04/2025 | Q2 | $382.5M | $382.7M | -$0.38 | -$0.23 | -$0.15 |
| 05/05/2025 | Q1 | $383.2M | $386.9M | -$0.04 | -$0.28 | $0.24 |
| 02/25/2025 | Q4 | $371M | $379.6M | -$0.36 | -$0.29 | -$0.07 |
| 11/04/2024 | Q3 | $380.2M | $373.6M | -$0.41 | -- | -- |
| 08/01/2024 | Q2 | $372.1M | $371.4M | -$0.41 | -$0.28 | -$0.13 |
| 05/06/2024 | Q1 | $370.6M | $370.8M | -$0.36 | -$0.28 | -$0.08 |
| 02/26/2024 | Q4 | $361M | $361.5M | -$0.43 | -$0.25 | -$0.18 |
| 11/01/2023 | Q3 | -- | -- | -$0.28 | -- | -- |
| 08/01/2023 | Q2 | -- | -- | -$0.30 | -- | -- |
| 05/08/2023 | Q1 | -- | -- | -$0.22 | -- | -- |
| 03/01/2023 | Q4 | -- | -- | -$0.27 | -$0.28 | $0.01 |
| 11/02/2022 | Q3 | -- | -- | -$0.34 | -$0.23 | -$0.11 |
| 08/03/2022 | Q2 | -- | -- | -$0.46 | -$0.29 | -$0.17 |
| 05/03/2022 | Q1 | -- | -- | $1.01 | $1.04 | -$0.03 |
| 02/23/2022 | Q4 | -- | -- | $1.54 | -$0.28 | $1.82 |
| 11/03/2021 | Q3 | -- | -- | -$0.38 | -$0.24 | -$0.14 |
| 08/04/2021 | Q2 | -- | -- | -$0.14 | -$0.24 | $0.10 |
| 05/05/2021 | Q1 | -- | -- | -$0.28 | -$0.24 | -$0.05 |
| 02/24/2021 | Q4 | -- | -- | -$0.07 | -$0.23 | $0.16 |
| 11/05/2020 | Q3 | -- | -- | -$0.45 | -$0.12 | -$0.33 |
| 08/06/2020 | Q2 | -- | -- | -$0.11 | -$0.16 | $0.05 |
| 05/07/2020 | Q1 | -- | -- | $0.04 | -$0.01 | $0.05 |
| 03/02/2020 | Q4 | -- | -- | -$0.22 | $0.03 | -$0.25 |
| 11/07/2019 | Q3 | -- | -- | -$0.12 | $0.02 | -$0.14 |
| 08/08/2019 | Q2 | -- | -- | -- | $0.07 | -- |
| 05/09/2019 | Q1 | -- | -- | -- | $0.10 | -- |
| 03/01/2019 | Q4 | -- | -- | -- | $0.20 | -- |
| 11/06/2018 | Q3 | -- | -- | -- | $0.12 | -- |
| 08/07/2018 | Q2 | -- | -- | -- | -- | -- |
| 05/09/2018 | Q1 | -- | -- | -- | -- | -- |
| 02/27/2018 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2017 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2017 | Q1 | -- | -- | -- | -- | -- |
| 02/27/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/04/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/05/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/23/2016 | Q4 | -- | -- | -- | -- | -- |
Diversified Healthcare Trust reported $388.7M worth of top line sales in its most recent quarter.
Diversified Healthcare Trust announced earnings per share of -$0.68 which represents a miss of analyst forecast a -$0.23 per share.
Diversified Healthcare Trust reported -$2M that represents -$0.01 per share over the last quarter.
Diversified Healthcare Trust's earnings are forecast to decrease from -$1.55 per share to -$1.47 per share next year representing a decrease of -33.36%.
Diversified Healthcare Trust's next earnings date is February 24, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.